Biotest AG/ DE0005227235 /
| 2024-10-22 4:40:44 PM | Chg. - | Volume | Bid1:17:15 PM | Ask4:24:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 27.50EUR | - | 2,341 Turnover: 59,180 |
-Bid Size: - | -Ask Size: - | 2.43 bill.EUR | 0.05% | 12.81 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.20 EUR | - |
| EPS Diluted: | - EUR | - |
| Revenues per Share: | 17.30 EUR | 32.65% |
| Book Value per Share: | 12.61 EUR | 34.44% |
| Cash Flow per Share: | -0.07 EUR | -93.33% |
| Dividend per Share: | 0.02 EUR | 0.00% |
| Total | in mill. | |
| Revenues: | 684.60 EUR | 32.65% |
| Net Income: | 127.00 EUR | - |
| Operating Cash Flow: | -2.70 EUR | - |
| Cash and Cash Equivalents: | 108.10 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 12.81 | 9.63 |
| P/S Ratio: | 2.37 | 1.79 |
| P/BV ratio: | 3.25 | 2.46 |
| P/CF Ratio: | -600.90 | -454.34 |
| PEG: | - | - |
| Earnings Yield: | 7.80% | 10.39% |
| Dividend Yield: | 0.05% | 0.06% |
| Market Capitalization | ||
| Market Capitalization: | 2.43 bill. EUR | 1.45 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 334,383.6628 EUR | 252,826.6719 EUR |
| Shares Outstanding: | 19.79 mill. | |
Profitability
| Gross Profit Margin: | 40.94% |
| EBIT Margin: | 20.96% |
| Net Profit Margin: | 18.55% |
| Return on Equity: | 25.46% |
| Return on Assets: | 9.00% |
Financial Strength
| Liquidity I / Cash Ratio: | 28.06% |
| Liquidity II / Quick Ratio: | 65.74% |
| Liquidity III / Current Ratio: | 196.34% |
| Debt / Equity Ratio: | 182.80% |
| Dynam. Debt / Equity Ratio: | -33,777.78% |
Efficiency
| Employees: | 2,426 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 282,192.91 EUR |
| Net Income / Employee: | 52,349.55 EUR |
| Total Assets / Employee: | 581,574.61 EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
